112 related articles for article (PubMed ID: 16289493)
1. Human primary renal cells as a model for toxicity assessment of chemo-therapeutic drugs.
Li W; Lam M; Choy D; Birkeland A; Sullivan ME; Post JM
Toxicol In Vitro; 2006 Aug; 20(5):669-76. PubMed ID: 16289493
[TBL] [Abstract][Full Text] [Related]
2. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening.
O'Brien PJ; Irwin W; Diaz D; Howard-Cofield E; Krejsa CM; Slaughter MR; Gao B; Kaludercic N; Angeline A; Bernardi P; Brain P; Hougham C
Arch Toxicol; 2006 Sep; 80(9):580-604. PubMed ID: 16598496
[TBL] [Abstract][Full Text] [Related]
3. The immediate early genes, c-fos, c-jun and AP-1, are early markers of platinum analogue toxicity in human proximal tubular cell primary cultures.
Wainford RD; Weaver RJ; Hawksworth GM
Toxicol In Vitro; 2009 Aug; 23(5):780-8. PubMed ID: 19383537
[TBL] [Abstract][Full Text] [Related]
4. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
Brenes O; Arce F; Gätjens-Boniche O; Díaz C
Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
[TBL] [Abstract][Full Text] [Related]
5. In vitro evaluation of clinical activity and toxicity of anticancer drugs using tumor cells from patients and cells representing normal tissues.
Haglund C; Aleskog A; Nygren P; Gullbo J; Höglund M; Wickström M; Larsson R; Lindhagen E
Cancer Chemother Pharmacol; 2012 Mar; 69(3):697-707. PubMed ID: 21984220
[TBL] [Abstract][Full Text] [Related]
6. Multiplexed assay panel of cytotoxicity in HK-2 cells for detection of renal proximal tubule injury potential of compounds.
Wu Y; Connors D; Barber L; Jayachandra S; Hanumegowda UM; Adams SP
Toxicol In Vitro; 2009 Sep; 23(6):1170-8. PubMed ID: 19523510
[TBL] [Abstract][Full Text] [Related]
7. Cell-based assays for profiling activity and safety properties of cancer drugs.
Li W; Lam MS; Birkeland A; Riffel A; Montana L; Sullivan ME; Post JM
J Pharmacol Toxicol Methods; 2006; 54(3):313-9. PubMed ID: 16675273
[TBL] [Abstract][Full Text] [Related]
8. Use of cellular electrical impedance sensing to assess in vitro cytotoxicity of anticancer drugs in a human kidney cell nephrotoxicity model.
Xie F; Xu Y; Wang L; Mitchelson K; Xing W; Cheng J
Analyst; 2012 Mar; 137(6):1343-50. PubMed ID: 22214987
[TBL] [Abstract][Full Text] [Related]
9. Metabolism and cytotoxic effects of T-2 toxin and its metabolites on human cells in primary culture.
Königs M; Mulac D; Schwerdt G; Gekle M; Humpf HU
Toxicology; 2009 Apr; 258(2-3):106-15. PubMed ID: 19428930
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
[TBL] [Abstract][Full Text] [Related]
11. Treatment of PC3 prostate cancer cells with mitoxantrone, etoposide, doxorubicin and carboplatin induces distinct alterations in the expression of kallikreins 5 and 11.
Thomadaki H; Mavridis K; Talieri M; Scorilas A
Thromb Haemost; 2009 Feb; 101(2):373-80. PubMed ID: 19190824
[TBL] [Abstract][Full Text] [Related]
12. [Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].
Xiao Y; Li JD; Shi HL; Liu JH; Feng YL; Li MD
Ai Zheng; 2007 Apr; 26(4):386-9. PubMed ID: 17430657
[TBL] [Abstract][Full Text] [Related]
13. Epithelial barrier characteristics and expression of cell adhesion molecules in proximal tubule-derived cell lines commonly used for in vitro toxicity studies.
Prozialeck WC; Edwards JR; Lamar PC; Smith CS
Toxicol In Vitro; 2006 Sep; 20(6):942-53. PubMed ID: 16387471
[TBL] [Abstract][Full Text] [Related]
14. Protodynamic therapy for bladder cancer: in vitro results of a novel treatment concept.
Laihia JK; Pylkkänen L; Laato M; Boström PJ; Leino L
BJU Int; 2009 Nov; 104(9):1233-8. PubMed ID: 19466948
[TBL] [Abstract][Full Text] [Related]
15. Effects of paclitaxel and doxorubicin in histocultures of hepatocelular carcinomas.
Chuu JJ; Liu JM; Tsou MH; Huang CL; Chen CP; Wang HS; Chen CT
J Biomed Sci; 2007 Mar; 14(2):233-44. PubMed ID: 17206490
[TBL] [Abstract][Full Text] [Related]
16. 3-D tumor model for in vitro evaluation of anticancer drugs.
Horning JL; Sahoo SK; Vijayaraghavalu S; Dimitrijevic S; Vasir JK; Jain TK; Panda AK; Labhasetwar V
Mol Pharm; 2008; 5(5):849-62. PubMed ID: 18680382
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity assessment of three therapeutic agents, cyclosporin-A, cisplatin and doxorubicin, with the ciliated protozoan Tetrahymena pyriformis.
Bonnet JL; Dusser M; Bohatier J; Laffosse J
Res Microbiol; 2003 Jun; 154(5):375-85. PubMed ID: 12837514
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic studies of anti-neoplastic drugs on human lymphocytes--in vitro studies.
Krishna IV; Vanaja GR; Kumar NS; Suman G
Cancer Biomark; 2009; 5(6):261-72. PubMed ID: 20037202
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 2-methoxyestradiol and methotrexate effects on non-Hodgkin's B-cell lymphoma.
Park J; Franco RS; Augsburger JJ; Banerjee RK
Curr Eye Res; 2007; 32(7-8):659-67. PubMed ID: 17852190
[TBL] [Abstract][Full Text] [Related]
20. Proliferation of human breast cancer cells and anti-cancer action of doxorubicin and vinblastine are independent of PKC-alpha.
Liu DS; Krebs CE; Liu SJ
J Cell Biochem; 2007 May; 101(2):517-28. PubMed ID: 17171646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
